PlainRecalls
FDA Devices Moderate Class II Terminated

Access System-GI Monitor (CA19-9), A83873D, Catalog No. 387687

Reported: July 5, 2017 Initiated: May 9, 2017 #Z-2638-2017

Product Description

Access System-GI Monitor (CA19-9), A83873D, Catalog No. 387687

Reason for Recall

The Access immunoassays are susceptible to biotin interference.

Details

Recalling Firm
Beckman Coulter Inc.
Units Affected
249,597 units total (9,388 units in US)
Distribution
Algeria, Angola, Australia, Austria, Bangladesh, Belgium, Bolivia, Bosnia and Herzegovina, Botswana, Brazil, Brunei, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Cyprus, Czech Republic, Denmark, Djibouti, Ecuador, Egypt, El Salvador, Estonia, Ethiopia, Finland, France, Georgia, Germany, Ghana, Gibraltar, Greece, Guam, Guatemala, Honduras, Hong Kong, Hungary, India, Indonesia, Ireland, Israel, Italy, Japan, Jordan, Kazakhstan, Kenya, Kuwait, Lebanon, Libya, Lithuania, Macau, Malawi, Malaysia, Mayotte, Mexico, Morocco, Myanmar, Namibia, Nepal, Netherlands, Netherlands Antillean, New Zealand, Nigeria, Norway, Oman, Pakistan, Panama, Paraguay, Peru, Philippines, Poland, Portugal, Puerto Rico, Qatar, Romania, Russia, Rwanda, Saudi Arabia, Serbia, Sierra Leone, Singapore, Slovakia, South Africa, South Korea, Spain, Sri Lanka, Swaziland, Sweden, Switzerland, Taiwan, Thailand, Tunisia, Turkey, Uganda, United Arab Emirates, United Kingdom, United States, Uruguay, Venezuela, Vietnam, Zambia, Zimbabwe
Location
Brea, CA

Frequently Asked Questions

What product was recalled?
Access System-GI Monitor (CA19-9), A83873D, Catalog No. 387687. Recalled by Beckman Coulter Inc.. Units affected: 249,597 units total (9,388 units in US).
Why was this product recalled?
The Access immunoassays are susceptible to biotin interference.
Which agency issued this recall?
This recall was issued by the FDA Devices on July 5, 2017. Severity: Moderate. Recall number: Z-2638-2017.